PerkinElmer Announces Acquisition of Prenatal and Newborn Screening Laboratory in India
News Sep 09, 2009
PerkinElmer, Inc. has announced that it has acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd., a laboratory in India that focuses on fetal, maternal and newborn health.
Surendra Genetics Labs was founded by Dr. S. Suresh, a leading fetal medicine expert and ultrasonologist. The laboratory is based in Chennai, India and provides testing services for pregnant mothers and newborns.
Ann-Christine Sundell, president, Genetic Screening, PerkinElmer, said, "The acquisition of Surendra Labs is a key component of PerkinElmer's global commitment to facilitate access to advanced fetal, maternal and child health screening and diagnostic technologies and services for the Indian public and clinicians. This will enable PerkinElmer to extend our offerings to ensure better health outcomes in pregnancy and of newborns, as well as introduce new technologies to the India market."
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.